Sem Sælands vei 3
Life sciences represent the largest priority area of the University of Oslo (UiO) and aim to support multidisciplinary collaboration and research mobility. Dr. Angela Lupattelli and PhD student Anna S. Frank in PharmaTox have both been granted funding by UiOLifeScience to support international project collaborations.
Several PharmaTox researchers attended the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 22-26 in Prague which was organized by the International Society of PharmacoEpidemiology (ISPE).
Read about the first PharmaTox Skill-swap event hosted by the Neurobiology and Toxicology laboratory.
PhD student Anna Frank was a Visiting Fellow at the Department of Biological Statistics and Computational Biology, Cornell University, New York, USA earlier this year. Read more about her stay.
PharmaTox's research is being noticed in the EU! Horizon magazine recently published the article "Finding drugs that are safe to take while pregnant".
Master's student Ana Sulovic defended her thesis on April 24th with the title "Mulige nevroutviklingsforstyrrelser av opioider - studier in vivo og i nevronkulturer"
Emil Aas Stoltenberg is a Fulbright grantee the academic year 2018-2019. Congratulations!
PharmaTox are arranging a mini-sympisum with the topic receptors in pharmacotoxicity.
Read the PharmaTox yearly report to see what PharmaTox researchers achieved in 2017.
PharmaTox post doc Kristina Gervin presented PharmaTox at Open day at the University of Oslo, March 8, 2018.
PharmaTox at MN´s Strategic Research Initiatives Seminar
Angela Lupattelli was recently interviewed by Titan concerning her new publication "Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children"
On February 15, PharmaTox arranged a New Year Kick Off!
Read more about the new article "Propionate enters GABAergic neurons, inhibits GABA transaminase, causes GABA accumulation and lethargy in a model of propionic acidemia".
“Do you get smarter from exercise?”
On January 10, 2018, The faculty of Mathematics and Natural Sciences at UiO arranged a seminar on the value of health data. At the seminar, Hedvig and Geir Kjetil gave a great presentation of PharmaTox, and some examples of the work we do.
Health data - Norway’s most valuable asset!
This study uses paracetamol in pregnancy as an example to introduce a method of clustering medication exposures longitudinally throughout pregnancy.
Associate professor Cecilie Morland and her group at the School of Pharmacy have been included as members in the PharmaTox Strategic Research Initiative. Below she presents herself and her group.
How can Norway become the leading country in e-health, innovation in the health sector and to secure easier access to health data and registers?
PharmaTox Post. Doc Kristina Gervin, engineer Magnus Leithaug and PhD students Haakon Edgetveit Nustad and Mari Spildrejorde attended the 2017 conference Epigenomics of Common Diseases at the Wellcome Genome Campus in Cambridge.
PharmaTox PhD student Martin Falck recently atttended the 14th National Stem Cell Networking Conference. He presented his work on in vitro studies using human embryonic stem cells to find out more on the biology behind the connection between prenatal exposure of paracetamol and risk of developing ADHD.
Eivind Ystrøm and Hedvig Nordeng are interviewed in Titan.no, forskning.no and fhi.no regarding the new article "Prenatal exposure to Acetaminophen and risk of ADHD"